Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Baldo

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Physiology|September 22, 2023
Opening the door to physiological impacts underlying opioid-induced respiratory depression and therapeutic strategies: focus on fentanylBrian A Baldo
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 27, 2024
Opioid-induced respiratory depression: clinical aspects and pathophysiology of the respiratory network effectsBrian A Baldo
Journal of Clinical Anesthesia|November 5, 2018
Anaphylaxis caused by sugammadex- rocuronium inclusion complex: What is the basis of the allergenic recognition?Brian A Baldo
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 5, 2015
Enzymes approved for human therapy: indications, mechanisms and adverse effectsBrian A Baldo
Drug Safety|April 3, 2015
Chimeric fusion proteins used for therapy: indications, mechanisms, and safetyBrian A Baldo
Allergy|June 8, 2019
Stability of neuromuscular blocking drugs used for skin testingBrian A Baldo
Oncoimmunology|November 20, 2013
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responsesBrian A Baldo
Current Research in Toxicology|June 23, 2022
Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndromeBrian A Baldo
British Journal of Anaesthesia|July 16, 2024
Pholcodine and allergy to neuromuscular blocking agents. Comment on Br J Anaesth 2024; 132: 457-60Brian A Baldo
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2017
Opioid Analgesic Drugs: Misuse, Toxicity, and HypersensitivityBrian A Baldo
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Physiology|September 22, 2023
Opening the door to physiological impacts underlying opioid-induced respiratory depression and therapeutic strategies: focus on fentanylBrian A Baldo
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 27, 2024
Opioid-induced respiratory depression: clinical aspects and pathophysiology of the respiratory network effectsBrian A Baldo
Journal of Clinical Anesthesia|November 5, 2018
Anaphylaxis caused by sugammadex- rocuronium inclusion complex: What is the basis of the allergenic recognition?Brian A Baldo
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 5, 2015
Enzymes approved for human therapy: indications, mechanisms and adverse effectsBrian A Baldo
Drug Safety|April 3, 2015
Chimeric fusion proteins used for therapy: indications, mechanisms, and safetyBrian A Baldo
Allergy|June 8, 2019
Stability of neuromuscular blocking drugs used for skin testingBrian A Baldo
Oncoimmunology|November 20, 2013
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responsesBrian A Baldo
Current Research in Toxicology|June 23, 2022
Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndromeBrian A Baldo
British Journal of Anaesthesia|July 16, 2024
Pholcodine and allergy to neuromuscular blocking agents. Comment on Br J Anaesth 2024; 132: 457-60Brian A Baldo
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2017
Opioid Analgesic Drugs: Misuse, Toxicity, and HypersensitivityBrian A Baldo
Pageof 7